NCT04133415

✓ Unanimous Initial: inpatient Requery: outpatient — The trial involves stereotactic body radiotherapy, which is typically administered in an outpatient setting.

✓ Unanimous Initial: outpatient

✓ Unanimous Initial: outpatient Requery: outpatient — The study involves stereotactic body radiotherapy (SBRT) delivered in 5 fractions with blood collection visits, which is typically performed on an outpatient basis where patients come for treatment sessions and go home the same day.

✓ Unanimous Initial: N/A Requery: feasibility RCT — The trial has a small enrollment of 20 and focuses on treatment-related adverse events as primary outcomes.

✓ Unanimous Initial: N/A Requery: feasibility RCT — The trial is a single-arm intervention with a small enrollment of n=20, a primary outcome focused on safety/adverse events (Grade 3 or higher), and lacks a sample size calculation for clinical effectiveness, indicating it is a pilot/feasibility study.

✓ Unanimous Initial: feasibility RCT Requery: feasibility RCT — This is a single-arm study with only 20 participants and a primary outcome focused on safety (adverse events), which indicates a feasibility/safety evaluation rather than a fully powered efficacy trial.

✓ Unanimous Initial: yes Requery: yes — The clinical trial involves Lattice stereotactic body radiation therapy, which is a physical process using equipment (radiation delivery system) to treat cancer.

✓ Unanimous Initial: no

✓ Unanimous Initial: no Requery: yes — The study involves Lattice Stereotactic Body Radiotherapy (SBRT), which uses physical radiation delivery equipment/medical devices to deliver precise radiation therapy.